Some of pharma’s biggest players — including Merck, Amgen, Abbvie, and Gilead — formed an alliance to fight looming M&A reforms.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The weight loss drug market could be worth $100 billion in the next few years. Naturally, other companies want in.
While they can’t predict the future, financial advisors are placing their bets on active investments, quantum computing, and more.
As retail investors booms, advisors are balancing full-service offerings with more hands-on advice options.
Investors have plenty of choices to gain exposure to the Magnificent 7, depending on how much risk or reward they choose to take.